Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtype-Reference-Cited by-同舟云学术

Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtype

Published:2016-03 Issue: Volume:10 Page:42-49
ISSN:2212-9685
Container-title:EuPA Open Proteomics
language:en
Short-container-title:EuPA Open Proteomics

Author:

Giusti Laura,Ciregia Federica,Bonotti Alessandra,Da Valle Ylenia,Donadio Elena,Boldrini Claudia,Foddis Rudy,Giannaccini Gino,Mazzoni Maria R.,Canessa Pier Aldo,Cristaudo Alfonso,Lucacchini Antonio^ORCID

Funder

Ministero della Salute

University of Pisa

Publisher

Elsevier BV

Reference35 articles.

1. Advances in malignant mesothelioma;Robinson;N. Engl. J. Med.,2005

2. Malignant pleural mesothelioma: a comprehensive review;Ismail-Khan;Cancer Control,2006

3. Challenges and controversies in the diagnosis of malignant mesothelioma: part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA;Henderson;J. Clin. Pathol.,2013

4. Systematic review of trimodality therapy for patients with malignant pleural mesothelioma;Cao;Ann. Cardiothorac. Surg.,2012

5. Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategies;Remon;Cancer Treat. Rev.,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma;Marine Drugs;2025-01-10

2. Role of Prosaposin and Extracellular Sulfatase Sulf-1 Detection in Pleural Effusions as Diagnostic Biomarkers of Malignant Mesothelioma;Biomedicines;2022-11-03

3. Identification of Redox-Sensitive Transcription Factors as Markers of Malignant Pleural Mesothelioma;Cancers;2021-03-07

4. Asbestos and Mesothelioma: What Is Recent Advance in Research on Asbestos-Induced Molecular Carcinogenesis?;Respiratory Disease Series: Diagnostic Tools and Disease Managements;2021

5. New vistas in malignant mesothelioma: MicroRNA architecture and NRF2/MAPK signal transduction;Life Sciences;2020-09